International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies - Top-Institutions - MDSpire

International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies

  • By

  • Anne Brédart

  • Jean-Luc Kop

  • Omar Shamieh

  • Louis Fox

  • Waleed Alrjoub

  • Thierry Conroy

  • Nazim Serdar Turhal

  • I. Juan Arraras

  • Renée Bultijnck

  • Amélie Harle

  • Mieke Van Hemelrijck

  • Eleonora Pinto

  • Eric J. U. Roth

  • Georgios Ioannidis

  • Anna Costantini

  • Tara Chalk

  • Teresa Young

  • Gudrun Rohde

  • Hiroto Ishiki

  • Yuichiro Kikawa

  • Heike Schmidt

  • Vassilios Vassiliou

  • Stephanie Shayler

  • Frédéric Marchal

  • Anota Amélie

  • Jens Lehmann

  • November 26, 2025

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group
    European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group

    Brussels, Belgium

    Key Differentiators

    • Oncology
    • Quality of Life Research
    • Patient-Reported Outcomes

  • #2

    Institut Curie
    Institut Curie

    Paris, France

    Key Differentiators

    • Oncology
    • Cancer Research
    • Patient-Centered Care

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Patient-Reported Outcomes
    • Quality of Life Research

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Psychosocial Oncology
    • Patient Satisfaction Research

  • #5

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Quality of Life Research
    • Patient-Reported Outcomes

Original Source(s)

International Prospective Validation of the EORTC Core Questionnaire for Patient Satisfaction (EORTC PATSAT-C33) and the Outpatient Module (EORTC OUT-PATSAT7) in Phase IV Studies

  • by Anne Brédart, Jean-Luc Kop, Omar Shamieh, Louis Fox, Waleed Alrjoub, Thierry Conroy, Nazim Serdar Turhal, I. Juan Arraras, Renée Bultijnck, Amélie Harle, Mieke Van Hemelrijck, Eleonora Pinto, Eric J. U. Roth, Georgios Ioannidis, Anna Costantini, Tara Chalk, Teresa Young, Gudrun Rohde, Hiroto Ishiki, Yuichiro Kikawa, Heike Schmidt, Vassilios Vassiliou, Stephanie Shayler, Frédéric Marchal, Anota Amélie, Jens Lehmann

  • November 26, 2025

Related Content

Diagnosing and Treating Ocular Lymphoma

At the 2026 Retina World Congress meeting, Kapil Mishra, MD, explained how new diagnostic tools and treatment agents are refining management of PVRL.

Towards human-centric intelligent treatment planning for radiation therapy

Trends in obesity-related cardiovascular and cancer mortality in Switzerland 1995-2019: an analysis of multiple causes of death